Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients

Presently, there is inconclusive evidence regarding the most effective treatment for idiopathic nonhistaminergic acquired angioedema (InH-AAE). Omalizumab may, however, prove to be a promising option. This case report describes two patients who presented with recurrent angioedema attacks, which was...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetta, Enrico, Shiffer, Dana, Folci, Marco, Achenza, Maria I. S., Puggioni, Francesca, Heffler, Enrico, Furlan, Raffaello, Canonica, Giorgio W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081528/
https://www.ncbi.nlm.nih.gov/pubmed/30140474
http://dx.doi.org/10.1155/2018/8067610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081528/
https://www.ncbi.nlm.nih.gov/pubmed/30140474
http://dx.doi.org/10.1155/2018/8067610

Ejemplares similares